Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
advisory committee
Pharma
FDA review bodes well for MRD-based myeloma approvals
The FDA appears receptive to the idea of using MRD to support accelerated approvals of new multiple myeloma drugs, even though it has some questions.
Angus Liu
Apr 10, 2024 11:30am
FDA revokes approval of Oncopeptides' Pepaxto
Feb 23, 2024 11:10am
Sarepta's Elevidys expansion bid gets fast review without adcomm
Feb 16, 2024 11:05am
Amgen flunks Lumakras AdComm, but market pull looks unlikely
Oct 5, 2023 4:45pm
Alnylam wins expert backing for Onpattro in rare heart disease
Sep 13, 2023 5:30pm
We're back to a monovalent booster, FDA advisory committee says
Jun 16, 2023 11:10am